To Dose or Not to Dose?
Prescribing low-dose aspirin for preventing secondary cardiovascular disease is well established, but its safety and efficacy in primary prevention remains open to debate.
Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
An Overview of Naloxone for Pharmacists
The most common medications involved in prescription-opioid overdose deaths include methadone, oxycodone, and hydrocodone.
CMS Initiatives Regarding Pain-Management Issues
In 2018, CMS adopted a three-pronged approach to the public-health emergency posed by opioid use.
Peripheral Arterial Disease From a Community Pharmacy Perspective
Peripheral arterial disease (PAD) describes a phenomenon in which circulation to the leg is diminished due to atherosclerosis, resulting in reduced blood flow and often causing pain that can be limiting to those who experience it.
Pain, Agitation, and Delirium: A Review of Pertinent Guideline Updates for Pharmacists
Treating pain can help decrease agitation, while limiting sedation can help prevent delirium within the ICU.
Copyright © 2000 - 2025 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.